Facilitating Access to Approved Medication
Get Access To Teprotumumab-Trbw For Injection
- API: teprotumumab-trbw
- Packaging: injection
- Strength: For Injection: 500 mg lyophilized powder in a single-dose vial for reconstitution
WHAT IS TEPROTUMUMAB-TRBW, AND WHAT IT IS USED FOR?
Teprotumumab, is a medication used to treat adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to bulge outwards.
The most common side effects are muscle spasm, nausea, hair loss, diarrhea, fatigue, high blood sugar, hearing loss, dry skin, altered sense of taste and headache. Teprotumumab should not be used if pregnant, and women of child-bearing potential should have their pregnancy status verified prior to beginning treatment and should be counseled on pregnancy prevention during treatment and for six months following the last dose.
It is a human monoclonal antibody developed by Genmab and Roche for tumour treatment but was later researched to be used for ophthalmic uses. It binds to IGF-1R.
Teprotumumab was approved for use in the United States in January 2020. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Note: (For Prescribing Information Approved Drugs, see)
- The Food and Drug Administration (FDA), USA.
- The European Medicines Agency (EMA).
All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. teprotumumab-trbw for injection is a pharmaceutical drug To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.